Introduction
Obesity is a serious problem that affects millions of people around the world. Moreover, it heightens the risks for diabetes, heart disease, and a host of other health complications. As such, it is essential to adopt effective weight loss strategies to sustain weight loss and for long-term health. Bariatric surgery, in particular, has long been the gold standard for significantly shedding pounds.
Amid the weight loss landscape, however, GLP-1 receptor agonists may provide an alternative. Could these medications potentially replace bariatric surgery? In this guide, we go into the pros and cons of bariatric surgery and GLP-1 therapy, and how they work together.
Bariatric Surgery and Weight
Bariatrics is a medical field focused on obesity treatment and weight loss. Specifically, it includes lifestyle changes, medications, and surgical procedures. Traditional approaches involve diet and exercise. However, many struggle to achieve lasting results.
Bariatric surgery provides a powerful option for those with severe obesity. Specifically, it involves procedures like gastric bypass and sleeve gastrectomy, which significantly reduce food intake and alter metabolism. However, surgery carries risks, including complications, nutritional deficiencies, and lifelong adjustments.
With advancements in pharmaceuticals, GLP-1 receptor agonists have emerged as a potential game-changer in weight management.
What Is GLP-1?
GLP-1 (glucagon-like peptide-1) is a hormone that regulates blood sugar and appetite. In particular, it slows digestion, reduces hunger, and increases feelings of fullness. Meanwhile, GLP-1 receptor agonists mimic this natural hormone, helping patients eat less and lose weight.
Popular GLP-1 drugs include semaglutide (Ozempic, Wegovy), liraglutide (Saxenda, Victoza), and dulaglutide (Trulicity).
Drugmakers first developed these medications for type 2 diabetes. However, these showed significant weight loss benefits. Studies reveal that GLP-1 drugs help patients lose 10 to 15 percent of their body weight over several months.
While promising, they require long-term use. Stopping treatment often leads to weight regain, making sustainability a concern.
How Does Metformin Work?
Metformin is another medication often linked to weight management. In particular, it is primarily used to treat type 2 diabetes by lowering blood sugar and improving insulin sensitivity. Its weight loss effects result from decreased appetite, reduced glucose production, and enhanced insulin function.
However, these outcomes are modest versus GLP-1 receptor agonists. While metformin may help patients lose two to five percent of their body weight, GLP-1 drugs typically result in greater weight loss.
To strengthen metabolic benefits, Metformin is often combined with GLP-1 drugs. However, it does not replicate the effect of GLP-1 medications in suppressing appetite.
GLP-1 vs. Bariatric Surgery
Effectiveness
GLP-1 receptor agonists lead to an average 10 to 15 percent weight loss over 12-18 months. This is substantial. However, this is still lower than bariatric surgery, where patients often lose 25 to 30 percent of their body weight.
Long-Term Results
Weight loss surgery produces more durable results compared to medications. Many patients maintain significant weight loss for decades. On the other hand, they generally need to take GLP-1 drugs continuously to keep the weight off.
Risks and Side Effects
GLP-1 side effects include:
- Nausea, vomiting, diarrhea
- Increased risk of pancreatitis
- High cost and insurance barriers
Bariatric surgery risks:
- Surgical complications (bleeding, infections)
- Nutritional deficiencies
- Permanent lifestyle changes
Convenience and Accessibility
GLP-1 drugs offer a non-invasive alternative to surgery, making them attractive for those that are uncomfortable with operations. However, patients must take them indefinitely to sustain results.
Bariatric surgery requires a one-time procedure, but involves months of preparation and post-surgical care. Although it is also more expensive upfront, it may provide greater long-term cost savings compared to ongoing medication.
Alternative to Bariatric Surgery?
GLP-1 receptor agonists provide a powerful weight loss tool. But they are unlikely to fully replace surgery. As such, who are the best candidates for each approach?
GLP-1 drugs are best for:
- Patients with moderate obesity (BMI 30-40)
- Those seeking non-invasive treatments
- Individuals who prefer medication over surgery
- Diabetics needing dual glucose and weight management
Bariatric surgery is best for:
- Severely obese patients (BMI >40 or BMI >35 with health issues)
- Those who need significant, long-term weight loss
- Patients who have failed medication-based weight loss
GLP-1 medications may delay the need for surgery. In fact, a 2022-2023 study found that bariatric surgery declined with GLP-1 drug use for treating obesity.
Researchers from the Brigham and Women’s Hospital and Harvard T.H. Chan School of Public Health and the Brown School of Public Health found that GLP-1 drug use increased by 132.6 percent from 2022 to 2023. Moreover, during the same period, there was a 25.6 percent decline in bariatric surgeries to treat obesity.
However, GLP-1 drugs cannot fully replace bariatric surgery for all patients. As such, researchers are exploring combination approaches where medications are used before or after surgery to optimize results. Furthermore, they urge clinicians and policymakers to monitor access to effective obesity treatments as the treatment landscape expands.
“As patients with obesity increasingly rely on GLP-1s instead of surgical intervention, further research is needed to assess the impact of this shift from surgical to pharmacologic treatment of obesity on long-term patient outcomes,” said Thomas C. Tsai, MD, MPH, metabolic surgeon at Brigham and Women’s Hospital.
“With the national decline in utilization of metabolic bariatric surgery and potential closure of bariatric surgery programs, there is a concern that access to comprehensive multidisciplinary treatment of obesity involving pharmacologic, endoscopic, or surgical interventions may become more limited,” Tsai added.
Conclusion
GLP-1 receptor agonists are a breakthrough in obesity treatment, offering significant weight loss without surgery. However, they are not a one-size-fits-all solution. While they work well for moderate obesity, severely obese patients may still need bariatric surgery for lasting results.
For now, GLP-1 drugs and bariatric surgery remain complementary tools in the fight against obesity. Patients should consult healthcare professionals to determine the best option for their weight loss journey.
Frequently Asked Questions
1. Are GLP-1 drugs better than bariatric surgery?
It depends on the patient’s case. GLP-1 drugs work well for moderate obesity. Meanwhile, bariatric surgery provides greater and more permanent weight loss for severe cases.
2. Can I take GLP-1 medications after weight loss surgery?
Yes. Some patients use GLP-1 drugs after surgery to maintain weight loss or enhance their results.
3. What happens if I stop taking GLP-1 medications?
Most patients regain weight after stopping GLP-1 therapy. In particular, their appetite and digestion return to normal.
4. Is metformin a good weight loss medication?
Metformin can lead to modest weight loss, but it is less effective than GLP-1 drugs for obesity management.
5. Are GLP-1 drugs safe for long-term use?
Overall, studies suggest they are safe, but long-term effects are still being researched. However, some side effects, like nausea and pancreatitis, need monitoring.
6. Do GLP-1 drugs work without diet and exercise changes?
While they reduce hunger, it is best to combine them with healthy eating and physical activity to optimize weight loss results.
7. Does insurance cover GLP-1 medications?
Insurance coverage varies. Some plans cover diabetes-related prescriptions. But these may not include weight loss-specific GLP-1 drugs.
8. Will GLP-1 drugs replace weight loss surgery in the future?
It’s possible for some patients. However, bariatric surgery still remains the most effective long-term solution for severe obesity.
Image by prostooleh on Freepik
